Sun Pharmaceutical Industries Ltd. · SUNPHARMA
The daily read · from the close of 6 Oct
That day's whole fieldrank 578 of 856
Nifty in 10 sessions
In the middle of the field
-5.2% over 30 sessions · +2.6% vs Nifty over 90 · -9.6% vs its sector · 48% of its 52-week range. Layer percentiles across the field: L2 momentum 47.4, L3 vs market 22.6, L4 vs sector 34.0, L5 own record 33.6. The references are its own median ten-session rise and fall over the past year — arithmetic on its own history, not a price goal.
Its daily score over the last 60 sessions, oldest to newest; green when it sat in the top fifth, red in the bottom fifth. Of the 49 judged, 14 went the way its half of the field leaned.
How it has moved
All performers| Window | Move | vs Nifty | vs sector | vs itself | How it moved | Rank | |
|---|---|---|---|---|---|---|---|
| Week28 Sep on · 6 sessions | -2.6% | -1.0% | -0.9% | 16th pct | 2 of 6 up | 474 of 856 | |
| Month1 Sep on · 24 sessions | -9.1% | -3.7% | -6.8% | 2th pct | 8 of 24 up | 639 of 856 | |
| Quarter7 Jul on · 64 sessions | -5.7% | +1.1% | -8.3% | 1th pct | 28 of 64 up | 454 of 856 | |
| Half year7 Apr on · 125 sessions | +6.5% | +7.3% | -15.1% | 58th pct | 63 of 125 up | 494 of 855 | |
| Year7 Oct on · 246 sessions | +9.0% | +18.2% | -12.9% | 63th pct | 128 of 246 up | 309 of 855 |
The read
made on the morning of 25 Jul 2026 for Q1FY27Neutral — middle fifth of the companies reporting that week: rank 120 of 233, composite 50.7 out of 100. Moves 2.0% on results on average; has decoupled from the index while rising.
A neutral read points neither way; this site tallies it as such in its track record.
How it went: went nowhere much -5.1% vs market over the ten sessions after 31 Jul 2026 — the post-mortem is further down.
A read is a position on a screen, not advice. The label says where the composite ranked, the tally says how often that has gone the way it pointed, and the choice is the reader's.
The read · morning of 25 Jul 2026
for Q1FY27 on 31 Jul 2026Moves 2.0% on results on average; has decoupled from the index while rising.
Each layer is a percentile among this week's reporters (0–100). A missing layer's weight is spread over the others.
Composite = 0.30 × 8.9 + 0.20 × 66.8 + 0.30 × 91.0 + 0.20 × 36.9 = 50.7
Reactivity
Over the last 15 results the average absolute move from the session before the announcement to the session after was 2.0%. The largest was 6.7% (Q3FY26). The pre-result trend has continued and reversed in roughly equal measure, so the trend carries no historical information here.
- Typical move (T-1 → T+1)
- 2.0%
- Median move
- 1.7%
- Biggest
- +6.7% (Q3FY26)
- Up after 10 sessions
- 40% of 15
- Mean 10-session return
- +0.0%
- Mean 10-session vs market
- -0.4%
- Volume on result day
- 2.0× normal
- Pattern
- Mixed
Going in
Up 8.2% over 30 sessions and 6.3% over 90 sessions. Sitting at the 94th percentile of its 52-week range. Closed above its 20-day average on 90% of the last 30 sessions.
Normally tracks NIFTY 50 at a correlation of 0.35; over the last 30 sessions that has run at 0.16 (1.8 standard deviations from its own norm). Over 30 sessions it has outrun what its beta of 0.52 to the index would account for, by 6.8 percentage points. The move is the stock's own rather than the market's.
Over 90 sessions it has underperformed NIFTY PHARMA by 3.1 percentage points, and led it over the last 30 by 3.1. The strength belongs largely to the sector theme rather than the stock.
Where it sits
Beats market, lags sector over 90 sessions: +6.7% against the market, -3.1% against NIFTY PHARMA. Up and right is ahead of both; down and left is behind both.
Numbers behind the scores
- Share of reactions upward
- 47%
- Continuation ratio
- 45%
- Move spread (SD)
- 1.8%
- Average gap at open
- -0.03%
- 30-session return
- +8.2%
- 90-session return
- +6.3%
- Since last result
- +5.5% (42 sessions)
- 20-DMA vs 50-DMA
- +2.9%
- Sessions above 20-DMA
- 90%
- Position in 52-week range
- 94%
- Delivery, 30 / 90 sessions
- 60.8% / 61.6%
- Delivery trend
- -0.8 pp
- Benchmark
- NIFTY 50
- Correlation, 30 sessions / norm
- 0.17 / 0.35
- Correlation break
- 1.80 SD
- Beta, 30 / 90 sessions
- 0.18 / 0.34
- Alpha, 30 sessions
- +6.8%
- Market regime
- idiosyncratic accumulation
- Sector index
- NIFTY PHARMA
- vs sector, 30 / 90 sessions
- +3.1% / -3.1%
- Sector correlation / norm
- 0.77 / 0.75
- Quadrant score
- 40
- Evidence
- full · 15 results used
- Price band
- bluechip
What its results record says
16 results · ten sessions after each · from the close before the resultThis is the range each past result travelled, on closing prices. It is a description of the past, not a level for the next one, and this site gives no entry, exit or loss-limit levels.
Last 90 sessions
daily candles · adjusted for splits and bonuses · test patterns → · the outlook for the coming hours and days → · week by week: slope, patterns, next four weeks →Against the market and its sector
same 90 sessions · every line starts at 0%Around the last result · Q1FY27
ten sessions in, the result day, ten sessions out · from the close before the resultTen sessions after each result
share vs market vs sector · move from the close before the resultResults record
move from the close before each result| Quarter | Result day | Gap | T+1 | T+10 | Market T+10 | vs market | vs sector | Vol × | Result |
|---|---|---|---|---|---|---|---|---|---|
| Q1FY27 | 3 Aug 2026 | -0.4% | -1.3% | -5.5% | -0.4% | -5.1% | -4.7% | 1.6 | Rev 10% · PAT 27% YoY |
| Q4FY26 | 25 May 2026 | -0.2% | -0.2% | -3.0% | -2.5% | -0.5% | -1.3% | 0.6 | Rev 13% · PAT 26% YoY |
| Q3FY26 | 2 Feb 2026 | +2.4% | +6.7% | +6.6% | +1.4% | +5.2% | +3.4% | 1.0 | Rev 13% · PAT 16% YoY |
| Q2FY26 | 6 Nov 2025 | +0.5% | +0.1% | +5.2% | +2.3% | +2.8% | +3.6% | 1.9 | Rev 9% · PAT 3% YoY |
| Q1FY26 | 1 Aug 2025 | -1.0% | -3.8% | -4.3% | +0.4% | -4.8% | -1.6% | 4.9 | — |
| Q4FY25 | 23 May 2025 | -3.5% | -2.5% | -2.3% | +1.6% | -3.9% | -3.1% | 2.9 | Rev 8% · PAT -19% YoY |
| Q3FY25 | 3 Feb 2025 | +2.2% | +1.2% | -1.7% | -2.3% | +0.6% | -0.0% | 1.1 | — |
| Q2FY25 | 29 Oct 2024 | +1.0% | -2.7% | -5.4% | -1.9% | -3.5% | -2.3% | 1.3 | — |
| Q1FY25 | 2 Aug 2024 | -0.9% | +0.3% | +1.9% | -1.8% | +3.7% | -0.2% | 1.3 | — |
| Q4FY24 | 23 May 2024 | -1.9% | -3.4% | -4.3% | +1.0% | -5.3% | -3.9% | 4.7 | — |
| Q3FY24 | 1 Feb 2024 | +0.6% | -0.1% | +6.4% | +0.9% | +5.6% | +2.9% | 1.1 | Rev 10% · PAT 17% YoY |
| Q2FY24 | 2 Nov 2023 | +1.0% | +2.2% | +6.6% | +4.1% | +2.5% | +0.4% | 1.9 | Rev 11% · PAT 6% YoY |
| Q1FY24 | 4 Aug 2023 | -1.1% | +1.7% | -0.3% | +0.1% | -0.4% | -1.9% | 1.2 | — |
| Q4FY23 | 29 May 2023 | +0.0% | -1.1% | +1.4% | +0.3% | +1.1% | -0.6% | 2.1 | — |
| Q3FY23 | 1 Feb 2023 | +0.2% | -2.6% | -3.8% | +2.0% | -5.8% | -2.8% | 2.2 | — |
| Q2FY23 | 2 Nov 2022 | +0.2% | +0.7% | -2.2% | +1.1% | -3.3% | +1.8% | 2.1 | — |
Reported figures
₹ crore; from the exchange's XBRL filings| Quarter | Period end | Revenue | YoY | PAT | YoY | Op. margin | EPS |
|---|---|---|---|---|---|---|---|
| Q1FY27 | 30 Jun 2026 | 15,299 | +10.5% | 2,901 | +26.5% | 27.5% | 12.10 |
| Q4FY26 | 31 Mar 2026 | 14,611 | +12.8% | 2,709 | +25.8% | 27.1% | 11.30 |
| Q3FY26 | 31 Dec 2025 | 15,520 | +13.5% | 3,381 | +16.1% | 28.7% | 14.00 |
| Q2FY26 | 30 Sep 2025 | 14,478 | +8.9% | 3,124 | +2.9% | 31.3% | 13.00 |
| Q1FY26 | 30 Jun 2025 | 13,851 | — | 2,292 | — | 25.2% | 9.50 |
| Q4FY25 | 31 Mar 2025 | 12,958 | +8.1% | 2,153 | -19.0% | 25.9% | 9.00 |
| Q3FY25 | 31 Dec 2024 | 13,675 | — | 2,912 | — | 27.0% | 12.10 |
| Q2FY25 | 30 Sep 2024 | 13,291 | — | 3,037 | — | 29.6% | 12.70 |
| Q4FY24 | 31 Mar 2024 | 11,982 | — | 2,658 | — | 24.5% | 11.10 |
| Q3FY24 | 31 Dec 2023 | 12,380 | +10.1% | 2,560 | +17.4% | 27.5% | 10.50 |
| Q2FY24 | 30 Sep 2023 | 12,192 | +11.3% | 2,385 | +5.7% | 26.1% | 9.90 |
| Q1FY24 | 30 Jun 2023 | 11,940 | — | 2,005 | — | 25.2% | 8.40 |
Post-mortems
Every result in full →- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- Delivery share rose 5 points in the fortnight before — someone was taking stock home.
- 5 sector peers reported the same week; the sector read may already have been set.
- No reported figures on file for this quarter, so the result itself could not be judged.
- 4 sector peers reported the same week; the sector read may already have been set.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 5% of its 52-week low.
- Volume ran 1.9x its prior month in the fortnight before.
- 4 sector peers reported the same week; the sector read may already have been set.
- No reported figures on file for this quarter, so the result itself could not be judged.
- 11 sector peers reported the same week; the sector read may already have been set.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Its usual continuation pattern did not hold this quarter.
- 4 sector peers reported the same week; the sector read may already have been set.
- No reported figures on file for this quarter, so the result itself could not be judged.
- 5 sector peers reported the same week; the sector read may already have been set.
- No reported figures on file for this quarter, so the result itself could not be judged.
- 4 sector peers reported the same week; the sector read may already have been set.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- 3 sector peers reported the same week; the sector read may already have been set.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- 3 sector peers reported the same week; the sector read may already have been set.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- 5 sector peers reported the same week; the sector read may already have been set.
- No read was made before this result; recorded for the base rate.
- The market itself moved +4.1% over the same ten sessions; the raw move is mostly tide.
- Its sector moved +6.2% over the window.
- No reported figures on file for this quarter, so the result itself could not be judged.
- No read was made before this result; recorded for the base rate.